Cases selected for the AskAnzal weekly PMCPA insight newsletter
Bayer sponsored a BJMA UK meeting in Bolton (July 2013) with a stand and speaker. Panel found the…
A PV associate following up a Yellow Card report asked a pharmacy for patient contact details and DOB…
Bayer challenged Lixiana leavepiece claims. Panel found breaches where VTE βinitiationβ wording obscured heparin lead-in and where a…
Anonymous oncologist alleged overly frequent contact, unannounced clinic visits, old data and failure to leave copies. Panel found…
A Cymbalta detail aid implied duloxetine and venlafaxine XL had equivalent efficacy based on a single head-to-head study.…
Amgen admitted Aranesp (POM) branded materials were briefly displayed at a National Kidney Foundation conference accessible to patients/public.…
Complaint about clinical trial disclosure for ellaOne. PMCPA found the matter was outwith the scope of the ABPI…
Anonymous photos alleged doctors and wives entertained at a Chinese restaurant. With no agenda/invitation and a public venue,…
PMCPA ruled Ipsen breached Clause 3.2 after a speaker said they often started older/smaller patients on 40mg Cabometyx,…
A UK health professional said a Duac 5% Pulse Today banner was static and lacked prescribing info. GSK…
One real case. One key lesson. Every week β free.